Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
Clinical trial NCT06582745 · RECRUITING
Trial details
- NCT number
- NCT06582745
- Sponsor
- Cook Children's Health Care System
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2039-06-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.